Stevens Capital Management LP Bristol Myers Squibb CO Transaction History
Stevens Capital Management LP
- $703 Million
- Q3 2024
A detailed history of Stevens Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stevens Capital Management LP holds 28,492 shares of BMY stock, worth $1.64 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
28,492Holding current value
$1.64 Million% of portfolio
0.21%Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,620Shares Held
1.46BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.11 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.33 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.47 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...